Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19 [NA]
A completed clinical trial update focusing on asthma in families facing out-of-pocket costs due to COVID-19, with results posted.
-
FDA approval · 2022-03-01FDA Approved: PROVOCHOLINE — Supplemental Application (Methapharm Inc.)
FDA approved a supplemental application for Provocholine (methacholine chloride inhalation solution) submitted by Methapharm Inc.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility [Phase 2]
Phase 2 trial evaluating brodalumab vs placebo in adults with inadequately controlled asthma with high bronchodilator reversibility; termina…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics [Phase 3]
Phase 3 chronic-dose safety and efficacy study of Albuterol-HFA-BAI in pediatric asthmatics completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: physicAl aCtiviTy In minOrity womeN With Asthma Intervention [NA]
A completed clinical trial investigating physical activity intervention in minority women with asthma; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-21Clinical Trial Update: Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) [Phase 2]
Phase 2 study evaluating tezepelumab for airway inflammation in adults with uncontrolled asthma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472) [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of desloratadine syrup in children with seasonal allergic rhinitis with or without ast…
-
CLINICAL_TRIALS withdrawal · 2022-02-16Clinical Trial Update: Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115) [Phase 3]
A Phase 3 clinical trial evaluating mometasone furoate for persistent asthma in patients previously treated with low-dose inhaled corticoste…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators [NA]
A completed clinical trial evaluated whether treating caregiver depression improves childhood asthma outcomes and explored mediators of any …
-
CLINICAL_TRIALS withdrawal · 2022-02-14Clinical Trial Update: A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) [Phase 3]
Phase 3 trial comparing montelukast with fluticasone in pediatric chronic asthma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol [Phase 2]
Phase 2 trial assessing the protective effect of a fixed combination of disodium cromoglycate and reproterol in asthma with exercise-induced…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2) [Phase 2]
A Phase 2 study evaluating safety and efficacy of SelK2 on airway responses after allergen challenge in asthma and COPD; study completed.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075) [Phase 4]
Phase 4 trial evaluating montelukast sodium with concomitant inhaled budesonide in asthmatic patients has completed.
-
CLINICAL_TRIALS withdrawal · 2022-02-01Clinical Trial Update: Benralizumab in the Treatment of Patients With Severe Asthma With ABPA [Phase 4]
A Phase 4 trial evaluating benralizumab for severe asthma with ABPA has been withdrawn.
-
FDA approval · 2022-01-27FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application to market ProAir DigiHaler, a digital inhaler version of albuterol sulfate.
-
FDA approval · 2022-01-27FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Fluticasone Propionate and Salmeterol submitted by Teva Pharmaceuticals USA, Inc. The approval u…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients [Phase 2]
Phase 2 trial update comparing Z7200 and Symbicort Turbohaler on respiratory imaging parameters in asthmatic patients; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetics study of budesonide/formoterol (Z7200) in healthy volunteers completed.
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Clinical Study to Evaluate Z7200 Pharmacokinetics Profile [Phase 1]
Phase 1 pharmacokinetics study of Z7200 completed; results posted.
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Montelukast (generic, Sandoz Inc), updating the product's approval status under the ANDA. Montel…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc., enabling changes to its labeling or indica…
-
FDA approval · 2022-01-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., updating the labeling under an existing ap…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year [Phase 4]
A Phase 4 clinical trial evaluating the effects of an orally inhaled fluticasone furoate on growth velocity in prepubertal pediatric patient…
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma [Phase 3]
Phase 3 trial assessing budesonide/albuterol MDI for exercise-induced bronchoconstriction in adults and adolescents with asthma has complete…
-
FDA approval · 2021-12-28FDA Approved: ALBUTEROL SULFATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for albuterol sulfate by Mylan Pharmaceuticals Inc., making this generic bronchodilator available. It …